ArticleVaccines2026

mRNA Vaccines Targeting the Conserved SARS-CoV-2 Fusion Machinery Elicit Cross-Variant and Robust Immunity.

Jun Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.